AnaptysBio, Inc.
ANAB
$20.24
-$0.12-0.59%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 265.71M | 339.94M | 385.37M | 430.12M | 350.80M |
| Total Receivables | 21.42M | 17.88M | 40.77M | 12.20M | 9.01M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.78M | 5.29M | 5.74M | 6.37M | 7.54M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 291.91M | 363.11M | 431.88M | 448.68M | 367.35M |
|
|
|||||
| Total Current Assets | 291.91M | 363.11M | 431.88M | 448.68M | 367.35M |
| Net Property, Plant & Equipment | 15.09M | 15.66M | 16.23M | 16.57M | 17.12M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 256.00K | 256.00K | 256.00K | 256.00K | 256.00K |
| Total Assets | 335.25M | 422.05M | 483.83M | 493.42M | 427.38M |
|
|
|||||
| Total Accounts Payable | 3.33M | 6.12M | 4.00M | 3.59M | 4.89M |
| Total Accrued Expenses | 29.72M | 31.45M | 39.50M | 37.95M | 33.22M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.00M | 1.96M | 1.93M | 1.89M | 1.85M |
| Total Finance Division Other Current Liabilities | 480.00K | 4.50M | -- | 456.00K | 456.00K |
| Total Other Current Liabilities | 480.00K | 4.50M | -- | 456.00K | 456.00K |
| Total Current Liabilities | 35.53M | 44.04M | 45.43M | 43.88M | 40.42M |
|
|
|||||
| Total Current Liabilities | 35.53M | 44.04M | 45.43M | 43.88M | 40.42M |
| Long-Term Debt | 331.36M | 330.38M | 353.43M | 350.56M | 361.98M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 13.10M | 13.61M | 14.11M | 14.61M | 15.10M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 379.98M | 388.03M | 412.97M | 409.05M | 417.50M |
|
|
|||||
| Common Stock & APIC | 792.56M | 832.52M | 829.89M | 821.15M | 714.99M |
| Retained Earnings | -837.29M | -798.66M | -759.33M | -737.54M | -704.69M |
| Treasury Stock & Other | -6.00K | 161.00K | 305.00K | 759.00K | -415.00K |
| Total Common Equity | -44.73M | 34.02M | 70.87M | 84.37M | 9.88M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -44.73M | 34.02M | 70.87M | 84.37M | 9.88M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -44.73M | 34.02M | 70.87M | 84.37M | 9.88M |
|
|
|||||